Trials / Completed
CompletedNCT03287921
Diagnostic and Therapeutic Approaches to Hyperinflation and Small Airway Disease in COPD
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 26 (actual)
- Sponsor
- Universitätsmedizin Mannheim · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Current guideline-based criteria defining COPD do not meet the challenges set by the complex pathophysiology of the disease. Hyperinflation and affection of the small airways are two components that are not represented in current diagnostic concepts and may relate to early stages of the disease. Moreover, optimal therapeutic interventions in patients with these distinct features remain unclear. The investigators therefore aimed to evaluate novel or not widely used diagnostic approaches for the detection and initiating therapeutic strategies in early stage COPD within the GOLD recommendations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mono bronchodilatation | within indication according to current GOLD recommendation |
| DRUG | dual bronchodilatation | within indication according to current GOLD recommendation |
Timeline
- Start date
- 2017-10-02
- Primary completion
- 2018-11-30
- Completion
- 2019-04-11
- First posted
- 2017-09-19
- Last updated
- 2020-03-31
Locations
1 site across 1 country: Germany
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03287921. Inclusion in this directory is not an endorsement.